Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood

Clinical trial NCT03058809 · UNKNOWN

Trial details

NCT number: NCT03058809
Sponsor: Viatar LLC
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer

Start date: 2018-09-01
Primary completion: 2019-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.